Cargando…
Inhibition of the EGF Receptor by Binding to an Activating Kinase Domain Interface
Members of the epidermal growth factor receptor family (EGFR/Erb1, Erb2/HER2, ErbB3/HER3 and ErbB4/HER4) are key targets for inhibition in cancer therapy(1). Critical for activation is the formation of an asymmetric dimer by the intracellular kinase domains, in which the C-terminal lobe (C-lobe) of...
Autores principales: | Zhang, Xuewu, Pickin, Kerry A., Bose, Ron, Jura, Natalia, Cole, Philip A., Kuriyan, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561764/ https://www.ncbi.nlm.nih.gov/pubmed/18046415 http://dx.doi.org/10.1038/nature05998 |
Ejemplares similares
-
A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain
por: Levinson, Nicholas M, et al.
Publicado: (2006) -
Clozapine-dependent inhibition of EGF/neuregulin receptor (ErbB) kinases
por: Kobayashi, Yutaro, et al.
Publicado: (2019) -
The EGF receptor is an actin-binding protein
Publicado: (1992) -
Crystal structure of the kinase domain of a receptor tyrosine kinase from a choanoflagellate, Monosiga brevicollis
por: Bajaj, Teena, et al.
Publicado: (2023) -
Free Energy Landscape of Lipid Interactions with Regulatory
Binding Sites on the Transmembrane Domain of the EGF Receptor
por: Hedger, George, et al.
Publicado: (2016)